• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[医院焦虑抑郁量表(HADS)和一般健康问卷-12项版(GHQ-12)在检测乳腺癌患者精神疾病方面的准确性]

[The accuracy of HADS and GHQ-12 in detecting psychiatric morbidity in breast cancer patients].

作者信息

Krespi Boothby Margörit Rita, Hill Jonathan, Holcombe Christopher, Clark Louise, Fisher Jean, Salmon Peter

机构信息

Istanbul Bilim Universitesi, Istanbul.

出版信息

Turk Psikiyatri Derg. 2010 Spring;21(1):49-59.

PMID:20204904
Abstract

OBJECTIVE

Psychological problems should be identified in breast cancer patients proactively if doctors and nurses are to help them cope with the challenges imposed by their illness. Screening is one possible way to identify emotional problems proactively. Self-report questionnaires can be useful alternatives to carrying out psychiatric interviews during screening, because interviewing a large number of patients can be impractical due to limited resources. Two such measures are the Hospital Anxiety and Depression Scale (HADS) and the General Health Questionnaire-12 (GHQ-12).

METHOD

The present study aimed to compare the performance of the GHQ-12, and the HADS Unitary Scale and its subscales to that of the Schedule for Affective Disorders and Schizophrenia (SADS) in identifying patients with affective disorders, including DSM major depression and generalized anxiety disorder. The sample consisted of 296 female breast cancer patients who underwent surgery for breast cancer a year previously.

RESULTS

A small number of patients (11%) were identified as having DSM major depression or generalized anxiety disorder based on SADS score. The findings indicate that the optimal thresholds in detecting generalized anxiety disorder and DSM major depression with the HADS anxiety and depression subscales were > or = 8 and > or = 7, with 93.3% and 77.3% sensitivity, respectively, and 77.9% and 87.1% specificity, respectively. They also had a 21% and 36% positive predictive value, respectively. Using the HADS Unitary Scale the optimal threshold for detecting affective disorders was > or = 12, with 88.9% sensitivity, 80.7% specificity, and a 35% positive predictive value. In detecting affective disorders, the optimal threshold on the GHQ-12 was > or = 2, with 77.8% sensitivity and 70.2% specificity. This scale also had a 24% positive predictive value. In detecting generalized anxiety disorder and DSM major depression, the optimal thresholds on the GHQ-12 were > or = 2 and > or = 4 with 73.3% and 77.3% sensitivity, respectively, and 67.5% and 82% specificity, respectively. The scale also had 12% and 29% positive predictive values, respectively.

CONCLUSION

The HADS Unitary Scale and its subscales were effective in identifying affective disorders. They can be used as screening measures in breast cancer patients. The GHQ-12 was less accurate in detecting affective disorders than the HADS, but it can also be used as a screening instrument to detect affective disorders, generalized anxiety disorder, and DSM major depression.

摘要

目的

如果医生和护士想要帮助乳腺癌患者应对疾病带来的挑战,就应该主动识别他们的心理问题。筛查是主动识别情绪问题的一种可能方式。在筛查过程中,自我报告问卷可以作为进行精神科访谈的有用替代方法,因为由于资源有限,对大量患者进行访谈可能不切实际。医院焦虑抑郁量表(HADS)和一般健康问卷 - 12(GHQ - 12)就是这样两种测量工具。

方法

本研究旨在比较GHQ - 12、HADS单一量表及其子量表与情感障碍和精神分裂症检查表(SADS)在识别情感障碍患者(包括DSM重度抑郁症和广泛性焦虑症)方面的表现。样本包括296名一年前接受过乳腺癌手术的女性乳腺癌患者。

结果

根据SADS评分,少数患者(11%)被确定患有DSM重度抑郁症或广泛性焦虑症。研究结果表明,使用HADS焦虑和抑郁子量表检测广泛性焦虑症和DSM重度抑郁症的最佳阈值分别为≥8和≥7,敏感性分别为93.3%和77.3%,特异性分别为77.9%和87.1%。它们的阳性预测值分别为21%和36%。使用HADS单一量表检测情感障碍的最佳阈值为≥12,敏感性为88.9%,特异性为80.7%,阳性预测值为35%。在检测情感障碍时,GHQ - 12的最佳阈值为≥2,敏感性为77.8%,特异性为70.2%。该量表的阳性预测值也为24%。在检测广泛性焦虑症和DSM重度抑郁症时,GHQ - 12的最佳阈值分别为≥2和≥4,敏感性分别为73.3%和77.3%,特异性分别为67.5%和82%。该量表的阳性预测值分别为12%和29%。

结论

HADS单一量表及其子量表在识别情感障碍方面有效。它们可作为乳腺癌患者的筛查工具。GHQ - 12在检测情感障碍方面不如HADS准确,但它也可作为检测情感障碍、广泛性焦虑症和DSM重度抑郁症的筛查工具。

相似文献

1
[The accuracy of HADS and GHQ-12 in detecting psychiatric morbidity in breast cancer patients].[医院焦虑抑郁量表(HADS)和一般健康问卷-12项版(GHQ-12)在检测乳腺癌患者精神疾病方面的准确性]
Turk Psikiyatri Derg. 2010 Spring;21(1):49-59.
2
Psychiatric morbidity and its screening in Turkish women with breast cancer: a comparison between the HADS and SCID tests.土耳其乳腺癌女性的精神疾病发病率及其筛查:医院焦虑抑郁量表(HADS)与精神障碍诊断与统计手册(SCID)测试的比较
Psychooncology. 2008 Jul;17(7):668-75. doi: 10.1002/pon.1286.
3
Screening for depression and anxiety disorders in primary care patients.对初级保健患者进行抑郁症和焦虑症筛查。
Depress Anxiety. 2007;24(7):455-60. doi: 10.1002/da.20274.
4
Validation of the Hospital Anxiety and Depression Scale for use with multiple sclerosis patients.验证医院焦虑和抑郁量表在多发性硬化症患者中的使用。
Mult Scler. 2009 Dec;15(12):1518-24. doi: 10.1177/1352458509347150. Epub 2009 Nov 13.
5
Affective syndromes and their screening in cancer patients with early and stable disease: Italian ICD-10 data and performance of the Distress Thermometer from the Southern European Psycho-Oncology Study (SEPOS).早期病情稳定的癌症患者的情感综合征及其筛查:意大利国际疾病分类第10版数据以及来自南欧心理肿瘤学研究(SEPOS)的苦恼温度计的性能
J Affect Disord. 2009 Apr;114(1-3):193-9. doi: 10.1016/j.jad.2008.07.016. Epub 2008 Aug 30.
6
Prevalence and psychosocial factors of anxiety and depression in breast cancer patients.乳腺癌患者焦虑和抑郁的患病率及心理社会因素
J Med Assoc Thai. 2007 Oct;90(10):2164-74.
7
Validity of the Hospital Anxiety and Depression Scale to assess depression and anxiety following traumatic brain injury as compared with the Structured Clinical Interview for DSM-IV.与《精神疾病诊断与统计手册》第四版结构化临床访谈相比,医院焦虑抑郁量表用于评估创伤性脑损伤后抑郁和焦虑的效度。
J Affect Disord. 2009 Apr;114(1-3):94-102. doi: 10.1016/j.jad.2008.06.007. Epub 2008 Jul 25.
8
Reliability and validity of the Hospital Anxiety and Depression Scale and the Beck Depression Inventory (Full and FastScreen scales) in detecting depression in persons with hepatitis C.医院焦虑抑郁量表及贝克抑郁量表(完整版和快速筛查版)在丙型肝炎患者抑郁检测中的信度和效度
J Affect Disord. 2007 Jun;100(1-3):265-9. doi: 10.1016/j.jad.2006.10.020. Epub 2006 Dec 6.
9
Screening for anxiety and depression after stroke: comparison of the hospital anxiety and depression scale and the Montgomery and Asberg depression rating scale.中风后焦虑和抑郁的筛查:医院焦虑抑郁量表与蒙哥马利-艾斯伯格抑郁评定量表的比较
J Psychosom Res. 2009 Oct;67(4):325-32. doi: 10.1016/j.jpsychores.2009.03.007. Epub 2009 Apr 17.
10
Evaluation of screening instruments for depression and anxiety in breast cancer survivors.乳腺癌幸存者中抑郁和焦虑的筛查工具评估。
Breast Cancer Res Treat. 2010 Jul;122(2):573-8. doi: 10.1007/s10549-009-0669-6. Epub 2009 Dec 4.

引用本文的文献

1
Psychometric Properties of the Patient Health Questionnaire-9 in Patients With Breast Cancer.乳腺癌患者中患者健康问卷-9的心理测量特性
Psychiatry Investig. 2024 May;21(5):521-527. doi: 10.30773/pi.2023.0285. Epub 2024 May 23.
2
Using the GHQ-12 to screen for mental health problems among primary care patients: psychometrics and practical considerations.使用一般健康问卷-12(GHQ-12)对初级保健患者的心理健康问题进行筛查:心理测量学及实际考量
Int J Ment Health Syst. 2020 Aug 10;14:62. doi: 10.1186/s13033-020-00397-0. eCollection 2020.
3
The reciprocal relationship of ASD, ADHD, depressive symptoms and stress in parents of children with ASD and/or ADHD.
患有自闭症谱系障碍(ASD)和/或注意力缺陷多动障碍(ADHD)儿童的父母中,ASD、ADHD、抑郁症状与压力之间的相互关系。
J Autism Dev Disord. 2014 May;44(5):1064-76. doi: 10.1007/s10803-013-1958-9.
4
DNA-testing for BRCA1/2 prior to genetic counselling in patients with breast cancer: design of an intervention study, DNA-direct.BRCA1/2 基因检测在乳腺癌患者遗传咨询前:一项干预研究的设计,DNA 直接研究。
BMC Womens Health. 2012 May 8;12:12. doi: 10.1186/1472-6874-12-12.
5
Treatment-related side effects and quality of life in cancer patients.癌症患者的治疗相关副作用和生活质量。
Support Care Cancer. 2012 Oct;20(10):2553-7. doi: 10.1007/s00520-011-1354-y. Epub 2012 Jan 21.
6
Depression screening and patient outcomes in cancer: a systematic review.癌症患者的抑郁筛查与患者结局:系统评价。
PLoS One. 2011;6(11):e27181. doi: 10.1371/journal.pone.0027181. Epub 2011 Nov 14.